JPH0417163B2 - - Google Patents
Info
- Publication number
- JPH0417163B2 JPH0417163B2 JP58502667A JP50266783A JPH0417163B2 JP H0417163 B2 JPH0417163 B2 JP H0417163B2 JP 58502667 A JP58502667 A JP 58502667A JP 50266783 A JP50266783 A JP 50266783A JP H0417163 B2 JPH0417163 B2 JP H0417163B2
- Authority
- JP
- Japan
- Prior art keywords
- quinidine
- coated
- weight
- pellets
- confectionery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 33
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 17
- 229960001404 quinidine Drugs 0.000 description 17
- 239000008188 pellet Substances 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 11
- 239000000203 mixture Substances 0.000 description 8
- 238000013268 sustained release Methods 0.000 description 7
- 239000012730 sustained-release form Substances 0.000 description 7
- AKYHKWQPZHDOBW-VJAUXQICSA-N (s)-[(2r,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;sulfuric acid Chemical compound OS(O)(=O)=O.C([C@H]([C@H](C1)C=C)C2)CN1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-VJAUXQICSA-N 0.000 description 6
- 229960002693 quinidine bisulfate Drugs 0.000 description 6
- 239000001856 Ethyl cellulose Substances 0.000 description 5
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 229920001249 ethyl cellulose Polymers 0.000 description 5
- 235000019325 ethyl cellulose Nutrition 0.000 description 5
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- -1 quinidine compound Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1983/001042 WO1984000295A1 (en) | 1982-07-09 | 1983-07-08 | Sustained release quinidine dosage form |
| US396669 | 1999-09-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59501214A JPS59501214A (ja) | 1984-07-12 |
| JPH0417163B2 true JPH0417163B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-03-25 |
Family
ID=22175337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58502667A Granted JPS59501214A (ja) | 1982-07-09 | 1983-07-08 | 持続性放出キニジン経口投与製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59501214A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
-
1983
- 1983-07-08 JP JP58502667A patent/JPS59501214A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59501214A (ja) | 1984-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4634587A (en) | Sustained release quinidine dosage form | |
| US4587118A (en) | Dry sustained release theophylline oral formulation | |
| EP0431877B1 (en) | Cimetidine pharmaceutical compositions | |
| CA2038245C (en) | Pharmaceutically useful micropellets | |
| TWI239838B (en) | Fluoxetine enteric pellets | |
| US4415547A (en) | Sustained-release pharmaceutical tablet and process for preparation thereof | |
| US5576022A (en) | Controlled release tacrine drug delivery systems and methods for preparing same | |
| EP0013263B1 (en) | A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof | |
| JP3258666B2 (ja) | 徐放性のブデゾナイドペレット及びその製造方法 | |
| KR20000029530A (ko) | 트라마돌다수단위제형 | |
| EP0164959A2 (en) | Pharmaceutical composition in sustained release unit dose form and process for its preparation | |
| KR970007899B1 (ko) | 맛 은폐를 위한 수단을 포함하는 저작가능한 의약 정제 | |
| EP0083372B1 (en) | Sustained release theophyline | |
| EP0212641A2 (en) | Taste masking compositions | |
| EP0538034B1 (en) | Taste mask coatings for preparing chewable pharmaceutical tablets | |
| CH646604A5 (fr) | Composition pharmaceutique a effet prolonge et son procede de fabrication. | |
| JPS5818318A (ja) | キサンチン誘導体の胃受容性薬剤の製法 | |
| RU2205006C2 (ru) | Фармацевтические композиции | |
| EP0113373B1 (en) | Sustained release quinidine dosage form | |
| US4786509A (en) | Dry sustained release theophylline oral formulation | |
| JPH0417163B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| NO774400L (no) | Fremgangsmaate til fremstilling av farmasoeytiske sammensetninger | |
| KR100193121B1 (ko) | 맛 차폐 및 서방성 약제용 피복물 | |
| JPS63162623A (ja) | ウラピジルおよび薬理学的に許容可能な脂肪族ジカルボン酸を含有する遅効ペレツト形の医薬 | |
| JPH01501936A (ja) | 持続放出型薬理組成物の製法およびこれにより得られる組成物 |